Bristol Myers Squibb reported $2.59B in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbott ABT:US $ 2388M 524M
Abbvie ABBV:US $ 3295M 1422M
ALKERMES ALKS:US -34457000 7.87M
Amgen AMGN:US $ 2176M 324M
AstraZeneca AZN:LN 44.27B 22.58B
Astrazeneca AZN:US 539M 339M
Biogen BIIB:US $ -59.1M 669.8M
Bristol Myers Squibb BMY:US $ 2590M 37M
Catalent CTLT:US $ 246M 35M
Coherus Biosciences CHRS:US $ -44.01M 43.13M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Gilead Sciences GILD:US $ 2029M 1832M
GlaxoSmithKline GSK:LN 108.1B 121.2B
Horizon Pharma HZNP:US $ 88.56M 105.76M
Intercept Pharmaceuticals ICPT:US $ -13.36M 3.09M
Johnson & Johnson JNJ:US $ 5840M 22M
Lannett LCI:US $ -77.96M 55.88M
Medtronic MDT:US $ 1125M 546M
Merk MRK:US $ 4927M 642M
Novartis NOVN:VX 2.23B 624M
Perrigo Ordinary Shares PRGO:US $ -16.2M 37.9M
Pfizer PFE:US $ 12102M 2229M
Prestige Brands PBH:US $ 87.01M 9.59M
Regeneron Pharmaceuticals REGN:US $ 1109.9M 148.6M
Revance Therapeutics RVNC:US $ -57842000 4.38M
Teva Pharmaceutical Industries TEVA:US $ -949M 236M
United Therapeutics UTHR:US $ 201.8M 84.5M
Zoetis ZTS:US $ 670M 57M